Cargando…
An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1
SIMPLE SUMMARY: Breast cancer is the most commonly diagnosed cancer in American women, and metastasis accounts for the majority of breast cancer-related deaths. The common metastatic sites for breast cancer includes the bones, lungs, brain, and liver. Breast cancer brain metastasis (BCBM) patients h...
Autores principales: | Doheny, Daniel, Manore, Sara, Sirkisoon, Sherona R., Zhu, Dongqin, Aguayo, Noah R., Harrison, Alexandria, Najjar, Mariana, Anguelov, Marlyn, Cox, Anderson O’Brien, Furdui, Cristina M., Watabe, Kounosuke, Hollis, Thomas, Thomas, Alexandra, Strowd, Roy, Lo, Hui-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454738/ https://www.ncbi.nlm.nih.gov/pubmed/36077791 http://dx.doi.org/10.3390/cancers14174256 |
Ejemplares similares
-
54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES
por: Doheny, Daniel, et al.
Publicado: (2020) -
BSCI-14. tGLI1 is an actionable therapeutic target in breast cancer brain metastases
por: Doheny, Daniel, et al.
Publicado: (2021) -
BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES
por: Doheny, Daniel, et al.
Publicado: (2019) -
BSCI-13. TUMOR-SPECIFIC tGLI1 TRANSCRIPTION FACTOR MEDIATES BREAST CANCER BRAIN METASTASIS VIA ACTIVATING METASTASIS-INITIATING CANCER STEM CELLS AND ASTROCYTES IN THE TUMOR MICROENVIRONMENT
por: Sirkisoon, Sherona, et al.
Publicado: (2019) -
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
por: Doheny, Daniel, et al.
Publicado: (2020)